Description
RGDopav1S is a high-performance regulatory element engineered for targeted gene expression in dopaminergic neurons. Spanning 251 bp, this promoter enables precise transcriptional control in Human DAT–expressing cells, making it a powerful tool for molecular biology, genetic engineering, and biomedical research.
Key Features
- Neuron-Specific Expression – Optimized to drive precise gene activation in Human DAT–positive neuronal cells.
- Experimentally Validated – Performance confirmed through in vitro studies, demonstrating reliable and reproducible expression.
- Flexible Research Applications – Suitable for a wide range of use cases, from basic neuroscience research to therapeutic development.
- Broad Compatibility – Designed for use in mouse and human expression systems.
Applications
- Functional genomics
- Disease modeling
- Gene therapy research
- Drug discovery
Target Tissue/Cell Type: Brain / Dopaminergic neurons (DAT-expressing)
Target Gene: DAT
Sequence Length (bp): 251